Bullish
The Osteonecrosis Treatment Market is projected to grow from US$ 637.18 million in 2022 to US$ 1,021.92 million by 2030, driven by early diagnosis, ad...
Neutral
MGO One Seven LLC grew its stake in shares of Novartis AG (NYSE:NVS – Free Report) by 22.6% during the fourth quarter, according to the company in its...
Neutral
MGO One Seven LLC grew its stake in shares of Novartis AG (NYSE:NVS – Free Report) by 22.6% in the 4th quarter, according to its most recent Form 13F ...
Neutral
Wilkins Investment Counsel Inc. cut its holdings in Novartis AG (NYSE:NVS – Free Report) by 13.1% during the 4th quarter, according to its most recent...